Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies On Objectively Measured Behavioral Outcomes: A Randomized Controlled Study

NCT04879758 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04879758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04879758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies On Objectively Measured Behavioral Outcomes: A Randomized Controlled Study
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Unknown status
Start date
July 7, 2021
Completion date
May 31, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exercise, fitness trackers, genetic predisposition to disease, sedentary behavior, type 2 diabetes